KXAN

Evommune Announces Late-Breaker Presentation of Phase 2 Data for EVO756 in Chronic Inducible Urticaria at Upcoming European Academy of Dermatology and Venereology (EADV) 2025 ...

PALO ALTO, Calif., Sept. 2, 2025 /PRNewswire/ -- Evommune, Inc., a clinical stage biotechnology company discovering and developing innovative therapies that target key drivers of chronic inflammatory ...
KXAN

The First Presentation of TEECAD Product Registry Data at the American Society of Echocardiography 2025 Conference

The TEECAD data and system users support the technology for effective and safe probe placement as part of the new clinical workflow structure "If we look at society guidelines for TEE going back 25 ...
Business Wire

Kairos Pharma Announces Presentation of New Phase 1 Data on ENV105 Combination Therapy in Non-Small Cell Lung Cancer at the World Lung Cancer Conference September 6-9, 2025

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces participation and ...
WKRN-TV

EDETEK Launches BioStat.AI: The Industry's First Unified AI Platform for Clinical Data, Biostatistics, and Programming

BioStat.AI is built on the foundation of EDETEK's flagship platforms, CONFORM™ and eClinical, and leverages advanced AI technologies including large language models (LLMs), machine learning, and ...